Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Articles from Emerging Infectious Diseases

Synopses

Medscape CME Activity
Haematospirillum jordaniae Infections after Recreational Exposure to River Water, Pennsylvania, USA, 2020 [PDF - 885 KB - 7 pages]
M. Dulcey et al.

Haematospirillum jordaniae was first identified as a human pathogen in 2016. In this article, we describe 4 patients who had H. jordaniae infections identified in 2020 and who had temporally and spatially linked environmental exposures. Three of the 4 patients reported leg injuries while participating in recreational river water activities in south-central Pennsylvania, USA. In 2024, we detected H. jordaniae in river samples collected at locations identified during patient interviews. All patients sought emergency department services for clinical assessment; however, the causative bacterial isolate was not initially identified. H. jordaniae was identified as the bacterial cause months after patient treatment and discharge. Although H. jordaniae infections are considered rare, the true occurrence is unknown. Additional information about the organism’s ecology and environmental seasonality could guide public health messaging and increase awareness among healthcare providers.

EID Dulcey M, DeBord KM, Bell ME, Murray MT, Szewc AM, Livingston K, et al. Haematospirillum jordaniae Infections after Recreational Exposure to River Water, Pennsylvania, USA, 2020. Emerg Infect Dis. 2025;31(11):2073-2079. https://doi.org/10.3201/eid3111.241586
AMA Dulcey M, DeBord KM, Bell ME, et al. Haematospirillum jordaniae Infections after Recreational Exposure to River Water, Pennsylvania, USA, 2020. Emerging Infectious Diseases. 2025;31(11):2073-2079. doi:10.3201/eid3111.241586.
APA Dulcey, M., DeBord, K. M., Bell, M. E., Murray, M. T., Szewc, A. M., Livingston, K....Bower, W. A. (2025). Haematospirillum jordaniae Infections after Recreational Exposure to River Water, Pennsylvania, USA, 2020. Emerging Infectious Diseases, 31(11), 2073-2079. https://doi.org/10.3201/eid3111.241586.

Trichosporon austroamericanum Infections among Hospitalized Patients, France, 2022–2024 [PDF - 1.98 MB - 11 pages]
E. Burel et al.

During 2022–2024, six cases of invasive fungal infection occurred among immunocompromised patients at Marseille University Hospital, Marseille, France. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry initially identified Trichosporon inkin fungi. However, phylogenetic analysis of intergenic spacer region 1 and whole-genome sequences revealed the genetically distinct species T. austroamericanum. Analysis of core genome and mitogenome from 6 patient isolates and 1 environmental isolate revealed substantial genetic diversity among T. austroamericanum strains, indicating a polyclonal outbreak. Furthermore, the mitochondrial genome emerged as a potential marker for intraspecies differentiation, which potentially could aid in epidemiologic investigations. Identified in 2024 but potentially underestimated, T. austroamericanum has since been reported in case clusters from hospital settings in France, highlighting the need for accurate fungal identification and suggesting previously identified T. inkin cases should be re-evaluated for T. austroamericanum. Clinical T. austroamericanum is emerging in hospital settings and should be included in the differential diagnosis of fungal infections.

EID Burel E, Sartor C, Moal V, Bossi V, Sevestre J, Solignac J, et al. Trichosporon austroamericanum Infections among Hospitalized Patients, France, 2022–2024. Emerg Infect Dis. 2025;31(11):2080-2090. https://doi.org/10.3201/eid3111.250503
AMA Burel E, Sartor C, Moal V, et al. Trichosporon austroamericanum Infections among Hospitalized Patients, France, 2022–2024. Emerging Infectious Diseases. 2025;31(11):2080-2090. doi:10.3201/eid3111.250503.
APA Burel, E., Sartor, C., Moal, V., Bossi, V., Sevestre, J., Solignac, J....Menu, E. (2025). Trichosporon austroamericanum Infections among Hospitalized Patients, France, 2022–2024. Emerging Infectious Diseases, 31(11), 2080-2090. https://doi.org/10.3201/eid3111.250503.
Research

Tickborne Neoehrlichia mikurensis in the Blood of Blood Donors, Norway, 2023 [PDF - 854 KB - 7 pages]
H. Quarsten et al.

The tickborne bacterial pathogen Neoehrlichia mikurensis has been detected in <1% of blood donors in Sweden. N. mikurensis can give rise to asymptomatic persistent infections. Up to 25% of Ixodes ricinus ticks in southern Norway are infected with N. mikurensis. We investigated the incidence of N. mikurensis infection among blood donors in this region. We detected N. mikurensis in the blood of 45/499 (9%) blood donors by independent PCR methods; 69% of those were repeatedly positive 1–7 months after the first detection and tested negative after doxycycline treatment. We tested 8/19 adult recipients of potentially infected blood; none tested positive for N. mikurensis at the time of testing (191–301 days after transfusion). Our study identified a very high rate of infection with N. mikurensis in blood donors in Norway; whether infection can be transmitted by transfusion of blood products, however, remains unclear.

EID Quarsten H, Ryen C, Mørk L, Wennerås C, Steinsvåg CT. Tickborne Neoehrlichia mikurensis in the Blood of Blood Donors, Norway, 2023. Emerg Infect Dis. 2025;31(11):2091-2097. https://doi.org/10.3201/eid3111.250125
AMA Quarsten H, Ryen C, Mørk L, et al. Tickborne Neoehrlichia mikurensis in the Blood of Blood Donors, Norway, 2023. Emerging Infectious Diseases. 2025;31(11):2091-2097. doi:10.3201/eid3111.250125.
APA Quarsten, H., Ryen, C., Mørk, L., Wennerås, C., & Steinsvåg, C. T. (2025). Tickborne Neoehrlichia mikurensis in the Blood of Blood Donors, Norway, 2023. Emerging Infectious Diseases, 31(11), 2091-2097. https://doi.org/10.3201/eid3111.250125.

Two Independent Acquisitions of Multidrug Resistance Gene lsaC in Streptococcus pneumoniae Serotype 20 Multilocus Sequence Type 1257 [PDF - 3.20 MB - 11 pages]
B. Beall et al.

Among >25,000 invasive pneumococcal disease isolates recovered in US locations during 2015–early 2024 through population-based surveillance, we detected 17 case isolates carrying the lsaC gene, which has been shown to confer resistance to clindamycin in group B Streptococcus. Sixteen isolates carried the mef, msrD, tetM, and lsaC genes on a 29-kb mobile element acquired through an interspecies recombination event and were intermediately clindamycin resistant. One isolate acquired a 62-kb mobile element containing the ermB, tetM, and lsaC genes through a transposition event. All 17 cases were in adults, including 4 adults experiencing homelessness and 9 with substance abuse problems. All 17 lsaC-positive isolates shared a 5.2-kb lsaC-containing element precisely integrated within the conserved oriT site of their respective mobile element. Those 17 lsaC-positive strains were all serotype 20, multilocus sequence type 1257, and were recovered recently (2021–2024); isolates 1–16 represented emergent disease clusters in New York and Connecticut.

EID Beall B, Lin W, Li Z, Tran T, Metcalf BJ, Anderson BJ, et al. Two Independent Acquisitions of Multidrug Resistance Gene lsaC in Streptococcus pneumoniae Serotype 20 Multilocus Sequence Type 1257. Emerg Infect Dis. 2025;31(11):2098-2108. https://doi.org/10.3201/eid3111.251101
AMA Beall B, Lin W, Li Z, et al. Two Independent Acquisitions of Multidrug Resistance Gene lsaC in Streptococcus pneumoniae Serotype 20 Multilocus Sequence Type 1257. Emerging Infectious Diseases. 2025;31(11):2098-2108. doi:10.3201/eid3111.251101.
APA Beall, B., Lin, W., Li, Z., Tran, T., Metcalf, B. J., Anderson, B. J....Chochua, S. (2025). Two Independent Acquisitions of Multidrug Resistance Gene lsaC in Streptococcus pneumoniae Serotype 20 Multilocus Sequence Type 1257. Emerging Infectious Diseases, 31(11), 2098-2108. https://doi.org/10.3201/eid3111.251101.

Community-Driven, Text Message–Based COVID-19 Surveillance System, Los Angeles County, California, USA, 2020–2024 [PDF - 1.93 MB - 9 pages]
J. B. Braunfeld et al.

Respiratory virus indicators were unreliable at the onset of the COVID-19 pandemic when testing availability was limited and residents with mild symptoms were advised to avoid unnecessary medical care. The Los Angeles County Department of Public Health (Los Angeles, California, USA) developed Angelenos in Action (AiA), a text message–based community syndromic surveillance system to monitor respiratory illness trends. Approximately 17,000 unique participants responded >1 time; 43% of participants continue to regularly respond to the survey. We assessed AiA’s performance by measuring correlation coefficients with reported COVID-19 case counts (0.975), sentinel laboratory SARS-CoV-2 test positivity rate (0.762), and wastewater SARS-CoV-2 concentrations (0.861). AiA performed strongly against 3 comparator surveillance methods and correlated particularly well with raw case counts. A moderate correlation was also noted between influenza test positivity rate and AiA data, indicating the system has potential to detect respiratory illness besides COVID-19.

EID Braunfeld JB, Traub E, Chiou H, Amoon AT, Collins C, Joyce A, et al. Community-Driven, Text Message–Based COVID-19 Surveillance System, Los Angeles County, California, USA, 2020–2024. Emerg Infect Dis. 2025;31(11):2109-2117. https://doi.org/10.3201/eid3111.250907
AMA Braunfeld JB, Traub E, Chiou H, et al. Community-Driven, Text Message–Based COVID-19 Surveillance System, Los Angeles County, California, USA, 2020–2024. Emerging Infectious Diseases. 2025;31(11):2109-2117. doi:10.3201/eid3111.250907.
APA Braunfeld, J. B., Traub, E., Chiou, H., Amoon, A. T., Collins, C., Joyce, A....de St. Maurice, A. (2025). Community-Driven, Text Message–Based COVID-19 Surveillance System, Los Angeles County, California, USA, 2020–2024. Emerging Infectious Diseases, 31(11), 2109-2117. https://doi.org/10.3201/eid3111.250907.

Isolation and Characterization of Rickettsia finnyi, Novel Pathogenic Spotted Fever Group Rickettsia in Dogs, United States [PDF - 1.92 MB - 10 pages]
P. K. Korla et al.

In 2020, a novel spotted fever group Rickettsia was described in 3 clinically ill dogs in the United States. Using naturally infected canine blood, the novel Rickettsia sp. was isolated in epithelial (Vero E6) and mononuclear (DH82 and 030D) cell lines. The sequenced whole genome revealed a 1.27 Mb circular chromosome with 96.87% identity to Rickettsia raoultii on the basis of average nucleotide identity analysis. A maximum-likelihood phylogeny tree placed the novel Rickettsia in its own branch within the spotted fever group. Immunofluorescence revealed single rods localized along the membrane in epithelial cells and randomly distributed in the cytoplasm of mononuclear cells. We propose the name Rickettsia finnyi sp. nov., strain 2024-CO-Wats, which is available from national and international Rickettsial isolate reference collections. Fever and thrombocytopenia were among abnormalities in the 17 naturally infected dogs we describe, underscoring the pathogenic importance of R. finnyi sp. nov. and its potential public health relevance.

EID Korla PK, Karounos MG, Clarke SB, Robveille C, Wilson JM, Breitschwerdt EB, et al. Isolation and Characterization of Rickettsia finnyi, Novel Pathogenic Spotted Fever Group Rickettsia in Dogs, United States. Emerg Infect Dis. 2025;31(11):2118-2127. https://doi.org/10.3201/eid3111.250681
AMA Korla PK, Karounos MG, Clarke SB, et al. Isolation and Characterization of Rickettsia finnyi, Novel Pathogenic Spotted Fever Group Rickettsia in Dogs, United States. Emerging Infectious Diseases. 2025;31(11):2118-2127. doi:10.3201/eid3111.250681.
APA Korla, P. K., Karounos, M. G., Clarke, S. B., Robveille, C., Wilson, J. M., Breitschwerdt, E. B....Qurollo, B. A. (2025). Isolation and Characterization of Rickettsia finnyi, Novel Pathogenic Spotted Fever Group Rickettsia in Dogs, United States. Emerging Infectious Diseases, 31(11), 2118-2127. https://doi.org/10.3201/eid3111.250681.

Monkeypox Virus Partial-Genome Amplicon Sequencing for Improvement of Genomic Surveillance during Mpox Outbreaks [PDF - 1.43 MB - 10 pages]
J. Deng et al.

Mpox is a reemerging infectious disease caused by monkeypox virus (MPXV). Whole-genome sequencing provides comprehensive surveillance of MPXV but is challenging in resource-limited outbreak settings and on clinical samples with low viral load. We developed a low-cost, high-throughput partial-genome sequencing strategy and a freeware Nextflow pipeline for MPXV genomic surveillance. We targeted 2 genomic regions of MPXV by using short overlapping amplicons. This amplicon-based approach generated high-quality sequences over the 2 genomic regions from clinical specimens, including samples with low viral DNA and from formalin-fixed tissues. This partial-genome sequencing approach can determine MPXV subclades and offers an attractive strategy to lower cost and improve MPXV surveillance during outbreaks in mpox-endemic and -nonendemic countries.

EID Deng J, McGrath D, Wilkins K, Haddock LA, Davidson W, Rabeneck DB, et al. Monkeypox Virus Partial-Genome Amplicon Sequencing for Improvement of Genomic Surveillance during Mpox Outbreaks. Emerg Infect Dis. 2025;31(11):2128-2137. https://doi.org/10.3201/eid3111.250548
AMA Deng J, McGrath D, Wilkins K, et al. Monkeypox Virus Partial-Genome Amplicon Sequencing for Improvement of Genomic Surveillance during Mpox Outbreaks. Emerging Infectious Diseases. 2025;31(11):2128-2137. doi:10.3201/eid3111.250548.
APA Deng, J., McGrath, D., Wilkins, K., Haddock, L. A., Davidson, W., Rabeneck, D. B....Gigante, C. (2025). Monkeypox Virus Partial-Genome Amplicon Sequencing for Improvement of Genomic Surveillance during Mpox Outbreaks. Emerging Infectious Diseases, 31(11), 2128-2137. https://doi.org/10.3201/eid3111.250548.
Dispatches

Bjerkandera spp. Pulmonary Infection in Immunocompromised Hosts, Germany [PDF - 1014 KB - 5 pages]
R. Sprute et al.

We report 3 cases of probable invasive pulmonary disease caused by Bjerkandera spp. fungi in immunocompromised patients in Germany. Accurate identification required internal transcribed spacer sequencing. Response to antifungal treatment varied. Our report underlines the pathogenic potential of Bjerkandera spp. and the importance of molecular diagnostics in rare fungal infections.

EID Sprute R, Seidel D, Mehler K, Westhues Z, Butzer SK, Stemler J, et al. Bjerkandera spp. Pulmonary Infection in Immunocompromised Hosts, Germany. Emerg Infect Dis. 2025;31(11):2138-2142. https://doi.org/10.3201/eid3111.250878
AMA Sprute R, Seidel D, Mehler K, et al. Bjerkandera spp. Pulmonary Infection in Immunocompromised Hosts, Germany. Emerging Infectious Diseases. 2025;31(11):2138-2142. doi:10.3201/eid3111.250878.
APA Sprute, R., Seidel, D., Mehler, K., Westhues, Z., Butzer, S. K., Stemler, J....Koehler, P. (2025). Bjerkandera spp. Pulmonary Infection in Immunocompromised Hosts, Germany. Emerging Infectious Diseases, 31(11), 2138-2142. https://doi.org/10.3201/eid3111.250878.

Novel Dolphin Tupavirus from Stranded Atlantic White-Sided Dolphin with Severe Encephalitis, Canada, 2024 [PDF - 2.01 MB - 5 pages]
O. Vernygora et al.

We sequenced a novel rhabdovirus, Tupavirus delphini (dolphin tupavirus), from the brain of a stranded dead Atlantic white-sided dolphin with severe encephalitis in Canada. In situ hybridization linked presence of the virus to the animal’s brain pathology and death. Our findings underscore the importance of monitoring marine mammals for unexpected pathogens.

EID Vernygora O, Bourque L, Jones M, Nielsen O, Embury-Hyatt C, Moffat E, et al. Novel Dolphin Tupavirus from Stranded Atlantic White-Sided Dolphin with Severe Encephalitis, Canada, 2024. Emerg Infect Dis. 2025;31(11):2144-2148. https://doi.org/10.3201/eid3111.251203
AMA Vernygora O, Bourque L, Jones M, et al. Novel Dolphin Tupavirus from Stranded Atlantic White-Sided Dolphin with Severe Encephalitis, Canada, 2024. Emerging Infectious Diseases. 2025;31(11):2144-2148. doi:10.3201/eid3111.251203.
APA Vernygora, O., Bourque, L., Jones, M., Nielsen, O., Embury-Hyatt, C., Moffat, E....Lung, O. (2025). Novel Dolphin Tupavirus from Stranded Atlantic White-Sided Dolphin with Severe Encephalitis, Canada, 2024. Emerging Infectious Diseases, 31(11), 2144-2148. https://doi.org/10.3201/eid3111.251203.

Neoehrlichia mikurensis in Ticks and Tick-Bitten Persons, Sweden and Finland, 2008–2009 [PDF - 586 KB - 4 pages]
E. Hero et al.

By using PCR testing, we found Neoehrlichia mikurensis DNA in 1.1% of ticks removed from persons in Sweden and Finland. Symptoms developed in 2 immunocompetent persons. Despite low transmission risk, infection can occur after short tick attachment. Our findings highlight the need to consider N. mikurensis in patients with unexplained symptoms after tick bite.

EID Hero E, Lager M, Forsberg P, Lindgren P, Henningsson AJ, Wilhelmsson P. Neoehrlichia mikurensis in Ticks and Tick-Bitten Persons, Sweden and Finland, 2008–2009. Emerg Infect Dis. 2025;31(11):2149-2152. https://doi.org/10.3201/eid3111.241850
AMA Hero E, Lager M, Forsberg P, et al. Neoehrlichia mikurensis in Ticks and Tick-Bitten Persons, Sweden and Finland, 2008–2009. Emerging Infectious Diseases. 2025;31(11):2149-2152. doi:10.3201/eid3111.241850.
APA Hero, E., Lager, M., Forsberg, P., Lindgren, P., Henningsson, A. J., & Wilhelmsson, P. (2025). Neoehrlichia mikurensis in Ticks and Tick-Bitten Persons, Sweden and Finland, 2008–2009. Emerging Infectious Diseases, 31(11), 2149-2152. https://doi.org/10.3201/eid3111.241850.

Shifting Dynamics of Dengue Virus Serotype 2 and Emergence of Cosmopolitan Genotype, Costa Rica, 2024 [PDF - 1.94 MB - 6 pages]
M. González-Elizondo et al.

Dengue remains a major public health challenge. In Costa Rica, we implemented nationwide genomic surveillance to track dengue virus serotype 2 cosmopolitan genotype emergence. Phylogenetic and eco-epidemiologic analyses revealed early detection, climate-driven spread, and spatial heterogeneity. Our findings underscore the need for integrated surveillance to guide adaptive responses to emerging arboviral threats.

EID González-Elizondo M, Soto D, Laurent E, Martínez F, Alcantara L, Fonseca V, et al. Shifting Dynamics of Dengue Virus Serotype 2 and Emergence of Cosmopolitan Genotype, Costa Rica, 2024. Emerg Infect Dis. 2025;31(11):2153-2158. https://doi.org/10.3201/eid3111.250746
AMA González-Elizondo M, Soto D, Laurent E, et al. Shifting Dynamics of Dengue Virus Serotype 2 and Emergence of Cosmopolitan Genotype, Costa Rica, 2024. Emerging Infectious Diseases. 2025;31(11):2153-2158. doi:10.3201/eid3111.250746.
APA González-Elizondo, M., Soto, D., Laurent, E., Martínez, F., Alcantara, L., Fonseca, V....Garita, C. (2025). Shifting Dynamics of Dengue Virus Serotype 2 and Emergence of Cosmopolitan Genotype, Costa Rica, 2024. Emerging Infectious Diseases, 31(11), 2153-2158. https://doi.org/10.3201/eid3111.250746.

Spiroplasma ixodetis in Ticks Removed from Humans, Sweden and Åland Islands, Finland [PDF - 955 KB - 4 pages]
M. Lager et al.

The prevalence of Spiroplasma ixodetis in ticks that have bitten humans in Sweden and in the Åland Islands, Finland, was 2.6%, with observed significant geographic differences between regions. The pathogen was not detected in blood samples from participants bitten by S. ixodetis–positive ticks, indicating low risk for transmission to humans.

EID Lager M, Alkattan Y, Karlsson A, Fernström L, Grankvist A, Wennerås C, et al. Spiroplasma ixodetis in Ticks Removed from Humans, Sweden and Åland Islands, Finland. Emerg Infect Dis. 2025;31(11):2159-2162. https://doi.org/10.3201/eid3111.250545
AMA Lager M, Alkattan Y, Karlsson A, et al. Spiroplasma ixodetis in Ticks Removed from Humans, Sweden and Åland Islands, Finland. Emerging Infectious Diseases. 2025;31(11):2159-2162. doi:10.3201/eid3111.250545.
APA Lager, M., Alkattan, Y., Karlsson, A., Fernström, L., Grankvist, A., Wennerås, C....Henningsson, A. J. (2025). Spiroplasma ixodetis in Ticks Removed from Humans, Sweden and Åland Islands, Finland. Emerging Infectious Diseases, 31(11), 2159-2162. https://doi.org/10.3201/eid3111.250545.

Two Autochthonous Cases of Anaplasmosis, Washington, USA, 2022–2023 [PDF - 1.06 MB - 4 pages]
H. Schnitzler et al.

We describe 2 cases of autochthonous human anaplasmosis in Washington, USA, where anaplasmosis has been rarely reported. Clinicians should consider anaplasmosis in the differential diagnosis for patients with compatible clinical symptoms after tick bite or time spent outdoors in an area where Ixodes pacificus ticks are present.

EID Schnitzler H, Chan M, Nybo J, Palmer-McGee K, Doobovsky Z, Tracy I, et al. Two Autochthonous Cases of Anaplasmosis, Washington, USA, 2022–2023. Emerg Infect Dis. 2025;31(11):2163-2166. https://doi.org/10.3201/eid3111.250379
AMA Schnitzler H, Chan M, Nybo J, et al. Two Autochthonous Cases of Anaplasmosis, Washington, USA, 2022–2023. Emerging Infectious Diseases. 2025;31(11):2163-2166. doi:10.3201/eid3111.250379.
APA Schnitzler, H., Chan, M., Nybo, J., Palmer-McGee, K., Doobovsky, Z., Tracy, I....Oltean, H. N. (2025). Two Autochthonous Cases of Anaplasmosis, Washington, USA, 2022–2023. Emerging Infectious Diseases, 31(11), 2163-2166. https://doi.org/10.3201/eid3111.250379.

Borrelia afzelii Hepatitis in Patient Treated with Venetoclax and Obinutuzumab, Switzerland [PDF - 3.07 MB - 5 pages]
G. Capoferri et al.

We report Borrelia afzelii hepatitis in an immunosuppressed patient in Switzerland receiving anti-CD20 therapy and venetoclax. Diagnosis was made by metagenomic sequencing and PCR. This case underscores the need to consider Lyme borreliosis in unexplained hepatitis cases and highlights the value of molecular diagnostics in immunosuppressed patients when serologic test results are negative.

EID Capoferri G, Battegay R, Hamelin B, Keller PM, Mertz KD, Weisser M. Borrelia afzelii Hepatitis in Patient Treated with Venetoclax and Obinutuzumab, Switzerland. Emerg Infect Dis. 2025;31(11):2167-2171. https://doi.org/10.3201/eid3111.250584
AMA Capoferri G, Battegay R, Hamelin B, et al. Borrelia afzelii Hepatitis in Patient Treated with Venetoclax and Obinutuzumab, Switzerland. Emerging Infectious Diseases. 2025;31(11):2167-2171. doi:10.3201/eid3111.250584.
APA Capoferri, G., Battegay, R., Hamelin, B., Keller, P. M., Mertz, K. D., & Weisser, M. (2025). Borrelia afzelii Hepatitis in Patient Treated with Venetoclax and Obinutuzumab, Switzerland. Emerging Infectious Diseases, 31(11), 2167-2171. https://doi.org/10.3201/eid3111.250584.
Research Letters

Two Cases of Autochthonous West Nile Virus Encephalitis, Paris, France, 2025 [PDF - 339 KB - 3 pages]
N. Hassold-Rugolino et al.

We report 2 cases of febrile lymphocytic meningitis with encephalitis in patients in France. One patient had not traveled outside Paris; the other had traveled to eastern France. Laboratory findings revealed acute West Nile virus infection. The cases occurred days apart, raising concern the virus has spread further in France.

EID Hassold-Rugolino N, Jaquet P, Da Silva D, Papa E, Calmettes J, Henry C, et al. Two Cases of Autochthonous West Nile Virus Encephalitis, Paris, France, 2025. Emerg Infect Dis. 2025;31(11):2172-2174. https://doi.org/10.3201/eid3111.251220
AMA Hassold-Rugolino N, Jaquet P, Da Silva D, et al. Two Cases of Autochthonous West Nile Virus Encephalitis, Paris, France, 2025. Emerging Infectious Diseases. 2025;31(11):2172-2174. doi:10.3201/eid3111.251220.
APA Hassold-Rugolino, N., Jaquet, P., Da Silva, D., Papa, E., Calmettes, J., Henry, C....Tandjaoui-Lambiotte, Y. (2025). Two Cases of Autochthonous West Nile Virus Encephalitis, Paris, France, 2025. Emerging Infectious Diseases, 31(11), 2172-2174. https://doi.org/10.3201/eid3111.251220.

Human Infection with Avian Influenza A(H10N3) Virus, China, 2024 [PDF - 1.15 MB - 3 pages]
J. Wang et al.

We describe the clinical symptoms and epidemiologic characteristics of a patient infected with avian influenza A(H10N3) virus in Guangxi Province, China, in December 2024. Whole-genome sequencing showed that the virus was highly homologous to a virus from Yunnan Province. H10 subtype viruses should be monitored for potential zoonotic or reassortant events.

EID Wang J, Bi F, Luo X, Huang H, Liang C, Zhao Y, et al. Human Infection with Avian Influenza A(H10N3) Virus, China, 2024. Emerg Infect Dis. 2025;31(11):2174-2176. https://doi.org/10.3201/eid3111.250847
AMA Wang J, Bi F, Luo X, et al. Human Infection with Avian Influenza A(H10N3) Virus, China, 2024. Emerging Infectious Diseases. 2025;31(11):2174-2176. doi:10.3201/eid3111.250847.
APA Wang, J., Bi, F., Luo, X., Huang, H., Liang, C., Zhao, Y....Lan, G. (2025). Human Infection with Avian Influenza A(H10N3) Virus, China, 2024. Emerging Infectious Diseases, 31(11), 2174-2176. https://doi.org/10.3201/eid3111.250847.

Detection of Aedes (Fredwardsius) vittatus Mosquitoes, Yucatán Peninsula, Mexico, 2025 [PDF - 859 KB - 3 pages]
R. J. Chan-Chable et al.

We report detection of Aedes (Fredwardsius) vittatus mosquitoes in continental North America, in Yucatán, Mexico. Phylogenetic analysis clustered the sequence from mosquitoes collected in Mexico with Caribbean mosquito lineages, suggesting species introduction via the Caribbean. Given its arbovirus competence, urgent inclusion of the Ae. vittatus mosquito in surveillance programs is warranted.

EID Chan-Chable RJ, Rodríguez-Luna CR, Espinal-Palomino R, Ibarra-Cerdeña CN. Detection of Aedes (Fredwardsius) vittatus Mosquitoes, Yucatán Peninsula, Mexico, 2025. Emerg Infect Dis. 2025;31(11):2177-2179. https://doi.org/10.3201/eid3111.251358
AMA Chan-Chable RJ, Rodríguez-Luna CR, Espinal-Palomino R, et al. Detection of Aedes (Fredwardsius) vittatus Mosquitoes, Yucatán Peninsula, Mexico, 2025. Emerging Infectious Diseases. 2025;31(11):2177-2179. doi:10.3201/eid3111.251358.
APA Chan-Chable, R. J., Rodríguez-Luna, C. R., Espinal-Palomino, R., & Ibarra-Cerdeña, C. N. (2025). Detection of Aedes (Fredwardsius) vittatus Mosquitoes, Yucatán Peninsula, Mexico, 2025. Emerging Infectious Diseases, 31(11), 2177-2179. https://doi.org/10.3201/eid3111.251358.

Fatal Tick-Borne Encephalitis in Unvaccinated Traveler from the United States to Switzerland, 2022 [PDF - 518 KB - 2 pages]
C. Scotti et al.

We report an unvaccinated traveler from the United States who contracted fulminant fatal tick-borne encephalitis while visiting Switzerland. Climate changes and international travel are intensifying tick exposure for unvaccinated persons. The increasing incidence of tick-borne encephalitis across Europe underscores the importance of tick bite prevention and vaccination against tick-borne encephalitis virus.

EID Scotti C, Greub G, Ahmad Y, Burgermeister S, Di Liberto G, Hewer E, et al. Fatal Tick-Borne Encephalitis in Unvaccinated Traveler from the United States to Switzerland, 2022. Emerg Infect Dis. 2025;31(11):2180-2181. https://doi.org/10.3201/eid3111.251320
AMA Scotti C, Greub G, Ahmad Y, et al. Fatal Tick-Borne Encephalitis in Unvaccinated Traveler from the United States to Switzerland, 2022. Emerging Infectious Diseases. 2025;31(11):2180-2181. doi:10.3201/eid3111.251320.
APA Scotti, C., Greub, G., Ahmad, Y., Burgermeister, S., Di Liberto, G., Hewer, E....Pantet, O. (2025). Fatal Tick-Borne Encephalitis in Unvaccinated Traveler from the United States to Switzerland, 2022. Emerging Infectious Diseases, 31(11), 2180-2181. https://doi.org/10.3201/eid3111.251320.

Crimean-Congo Hemorrhagic Fever Virus in Cattle and Ticks, Israel [PDF - 539 KB - 4 pages]
N. Rudoler et al.

We conducted a nationwide serologic and molecular survey to elucidate the epidemiologic status of Crimean-Congo hemorrhagic fever virus in Israel. We found serologic and molecular evidence of virus circulation in the country. Future human cases could be prevented by increasing public awareness and implementing public health measures.

EID Rudoler N, Rubinstein-Guini M, Roth A, Indenbaum V, Erster O, Lustig Y, et al. Crimean-Congo Hemorrhagic Fever Virus in Cattle and Ticks, Israel. Emerg Infect Dis. 2025;31(11):2182-2185. https://doi.org/10.3201/eid3111.250622
AMA Rudoler N, Rubinstein-Guini M, Roth A, et al. Crimean-Congo Hemorrhagic Fever Virus in Cattle and Ticks, Israel. Emerging Infectious Diseases. 2025;31(11):2182-2185. doi:10.3201/eid3111.250622.
APA Rudoler, N., Rubinstein-Guini, M., Roth, A., Indenbaum, V., Erster, O., Lustig, Y....Eliahoo, E. (2025). Crimean-Congo Hemorrhagic Fever Virus in Cattle and Ticks, Israel. Emerging Infectious Diseases, 31(11), 2182-2185. https://doi.org/10.3201/eid3111.250622.

Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho [PDF - 595 KB - 3 pages]
K. J. Seung et al.

A patient with extensively drug-resistant tuberculosis in Lesotho recovered successfully after failed treatment with bedaquiline, delamanid, linezolid, and clofazimine. Whole-genome sequencing and broth microdilution testing results were not in agreement, illustrating the urgent need for studies that correlate phenotypic and genotypic resistance testing with clinical response.

EID Seung KJ, Asfaw M, Kunda M, Maama-Maime L, Makaka J, Mofolo M, et al. Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho. Emerg Infect Dis. 2025;31(11):2185-2187. https://doi.org/10.3201/eid3111.250885
AMA Seung KJ, Asfaw M, Kunda M, et al. Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho. Emerging Infectious Diseases. 2025;31(11):2185-2187. doi:10.3201/eid3111.250885.
APA Seung, K. J., Asfaw, M., Kunda, M., Maama-Maime, L., Makaka, J., Mofolo, M....Oyewusi, L. (2025). Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho. Emerging Infectious Diseases, 31(11), 2185-2187. https://doi.org/10.3201/eid3111.250885.

Orientia tsutsugamushi Antibodies in Patients with Eschars and Suspected Tickborne Disease [PDF - 400 KB - 4 pages]
H. A. Abernathy et al.

To investigate local transmission of Orientia tsutsugamushi by chiggers in North Carolina, USA, we tested remnant serum specimens from patients with eschar undergoing testing for suspected tickborne disease. We identified 11 persons with O. tsutsugamushi antibodies, including 4 who were positive by both assays; none had severe clinical manifestations consistent with scrub typhus.

EID Abernathy HA, Ursery L, Merdjane BA, Giandomenico DA, Boyce RM. Orientia tsutsugamushi Antibodies in Patients with Eschars and Suspected Tickborne Disease. Emerg Infect Dis. 2025;31(11):2187-2190. https://doi.org/10.3201/eid3111.250763
AMA Abernathy HA, Ursery L, Merdjane BA, et al. Orientia tsutsugamushi Antibodies in Patients with Eschars and Suspected Tickborne Disease. Emerging Infectious Diseases. 2025;31(11):2187-2190. doi:10.3201/eid3111.250763.
APA Abernathy, H. A., Ursery, L., Merdjane, B. A., Giandomenico, D. A., & Boyce, R. M. (2025). Orientia tsutsugamushi Antibodies in Patients with Eschars and Suspected Tickborne Disease. Emerging Infectious Diseases, 31(11), 2187-2190. https://doi.org/10.3201/eid3111.250763.

Mortality Event in Rainbow Snakes Linked to Snake Fungal Disease, United States [PDF - 1.85 MB - 5 pages]
D. A. Conley et al.

We report mortality in rainbow snakes in Virginia and North Carolina, USA, linked to snake fungal disease caused by Ophidiomyces ophidiicola. During 2013–2023, we observed 46 dead rainbow snakes with lesions indicative of snake fungal disease, noted elevated disease severity compared with other species, and recorded fewer live snakes over time.

EID Conley DA, Blanvillain G, Miller JL, Langwig KE, Kleopfer JD, Lorch JM, et al. Mortality Event in Rainbow Snakes Linked to Snake Fungal Disease, United States. Emerg Infect Dis. 2025;31(11):2190-2193. https://doi.org/10.3201/eid3111.250547
AMA Conley DA, Blanvillain G, Miller JL, et al. Mortality Event in Rainbow Snakes Linked to Snake Fungal Disease, United States. Emerging Infectious Diseases. 2025;31(11):2190-2193. doi:10.3201/eid3111.250547.
APA Conley, D. A., Blanvillain, G., Miller, J. L., Langwig, K. E., Kleopfer, J. D., Lorch, J. M....Hoyt, J. R. (2025). Mortality Event in Rainbow Snakes Linked to Snake Fungal Disease, United States. Emerging Infectious Diseases, 31(11), 2190-2193. https://doi.org/10.3201/eid3111.250547.

Emergence of Dengue Virus Serotype 3, Lineage III_B.3.2, Angola [PDF - 956 KB - 4 pages]
J. de Vasconcelos et al.

We detected dengue virus serotype 3 in 11.8% (16/136) of febrile patients in Luanda Province, Angola, during April and July 2024. Our genetic analyses reveal that dengue virus serotype 3 lineage III_B.3.2 probably was imported from the Americas into Angola in late 2022 and then spread through local transmission.

EID de Vasconcelos J, Claro IM, de Araujo Eliodoro R, Moreira F, Pereira A, Samuel L, et al. Emergence of Dengue Virus Serotype 3, Lineage III_B.3.2, Angola. Emerg Infect Dis. 2025;31(11):2194-2197. https://doi.org/10.3201/eid3111.251079
AMA de Vasconcelos J, Claro IM, de Araujo Eliodoro R, et al. Emergence of Dengue Virus Serotype 3, Lineage III_B.3.2, Angola. Emerging Infectious Diseases. 2025;31(11):2194-2197. doi:10.3201/eid3111.251079.
APA de Vasconcelos, J., Claro, I. M., de Araujo Eliodoro, R., Moreira, F., Pereira, A., Samuel, L....Morais, J. (2025). Emergence of Dengue Virus Serotype 3, Lineage III_B.3.2, Angola. Emerging Infectious Diseases, 31(11), 2194-2197. https://doi.org/10.3201/eid3111.251079.

Yellow Fever Virus in Aedes albopictus Mosquitoes from Urban Green Area, São Paulo State, Brazil [PDF - 800 KB - 3 pages]
E. S. Bergo et al.

We detected yellow fever virus by using quantitative PCR in Aedes albopictus mosquitoes and isolated the virus in C6/36 cells in 4 of 18 pools, including 118 specimens collected in an urban green area in São Paulo State, Brazil. Additional monitoring to detect shifts in transmission of this species is warranted.

EID Bergo ES, de-Deus J, Mucci LF, Helfstein VC, Nascimento MC, Rocha N, et al. Yellow Fever Virus in Aedes albopictus Mosquitoes from Urban Green Area, São Paulo State, Brazil. Emerg Infect Dis. 2025;31(11):2197-2199. https://doi.org/10.3201/eid3111.250692
AMA Bergo ES, de-Deus J, Mucci LF, et al. Yellow Fever Virus in Aedes albopictus Mosquitoes from Urban Green Area, São Paulo State, Brazil. Emerging Infectious Diseases. 2025;31(11):2197-2199. doi:10.3201/eid3111.250692.
APA Bergo, E. S., de-Deus, J., Mucci, L. F., Helfstein, V. C., Nascimento, M. C., Rocha, N....Kirchgatter, K. (2025). Yellow Fever Virus in Aedes albopictus Mosquitoes from Urban Green Area, São Paulo State, Brazil. Emerging Infectious Diseases, 31(11), 2197-2199. https://doi.org/10.3201/eid3111.250692.

Molecular Evidence of Dengue Virus Serotype 2 in Travelers Returning to Israel from the Sinai Peninsula [PDF - 687 KB - 4 pages]
N. S. Zuckerman et al.

We report 4 dengue cases in travelers returning to Israel from Sharm-El-Sheikh, Egypt, all confirmed as dengue virus type 2 infections. Phylogenetic analysis showed clustering with strains from Pakistan. Our findings provide molecular evidence of dengue circulation in the Sinai desert, highlighting the need for increased awareness among travelers and health authorities.

EID Zuckerman NS, Choshen G, Lustig Y, Shoykhet A, Friedman K, Kushnir T, et al. Molecular Evidence of Dengue Virus Serotype 2 in Travelers Returning to Israel from the Sinai Peninsula. Emerg Infect Dis. 2025;31(11):2199-2202. https://doi.org/10.3201/eid3111.250991
AMA Zuckerman NS, Choshen G, Lustig Y, et al. Molecular Evidence of Dengue Virus Serotype 2 in Travelers Returning to Israel from the Sinai Peninsula. Emerging Infectious Diseases. 2025;31(11):2199-2202. doi:10.3201/eid3111.250991.
APA Zuckerman, N. S., Choshen, G., Lustig, Y., Shoykhet, A., Friedman, K., Kushnir, T....Schwartz, E. (2025). Molecular Evidence of Dengue Virus Serotype 2 in Travelers Returning to Israel from the Sinai Peninsula. Emerging Infectious Diseases, 31(11), 2199-2202. https://doi.org/10.3201/eid3111.250991.
Etymologia

Cladophialophora carrionii [kladˊ-ō-fī-əl-ō-for-ə karˊ-ē-ō-nē-ī] [PDF - 1013 KB - 1 page]
D. Moraes et al.
EID Moraes D, Bailão A, Bailão M. Cladophialophora carrionii [kladˊ-ō-fī-əl-ō-for-ə karˊ-ē-ō-nē-ī]. Emerg Infect Dis. 2025;31(11):2143. https://doi.org/10.3201/eid3111.240204
AMA Moraes D, Bailão A, Bailão M. Cladophialophora carrionii [kladˊ-ō-fī-əl-ō-for-ə karˊ-ē-ō-nē-ī]. Emerging Infectious Diseases. 2025;31(11):2143. doi:10.3201/eid3111.240204.
APA Moraes, D., Bailão, A., & Bailão, M. (2025). Cladophialophora carrionii [kladˊ-ō-fī-əl-ō-for-ə karˊ-ē-ō-nē-ī]. Emerging Infectious Diseases, 31(11), 2143. https://doi.org/10.3201/eid3111.240204.
About the Cover

Viewing Rural Life through a Public Health Lens [PDF - 2.15 MB - 3 pages]
N. M. M’ikanatha et al.
EID M’ikanatha NM, Welliver DP, Breedlove B. Viewing Rural Life through a Public Health Lens. Emerg Infect Dis. 2025;31(11):2203-2205. https://doi.org/10.3201/eid3111.ac3111
AMA M’ikanatha NM, Welliver DP, Breedlove B. Viewing Rural Life through a Public Health Lens. Emerging Infectious Diseases. 2025;31(11):2203-2205. doi:10.3201/eid3111.ac3111.
APA M’ikanatha, N. M., Welliver, D. P., & Breedlove, B. (2025). Viewing Rural Life through a Public Health Lens. Emerging Infectious Diseases, 31(11), 2203-2205. https://doi.org/10.3201/eid3111.ac3111.
Page created: December 04, 2025
Page updated: December 10, 2025
Page reviewed: December 10, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external